It may not have been pretty, but Regulus Therapeutics ($RGLS) raised close to $81 million from its recent IPO and some related transactions. And the company did it with a big assist from some major league partners in the biopharma industry. Report
| Tuesday, December 1st | 11am ET / 8am PT | Presented by: BIOVIA
Learn in this webinar how a comprehensive centralized chemicals Inventory system that is tightly integrated with other lab informatics systems – such as Electronic Lab Notebooks – reduces chemical management safety and compliance risks, allows laboratories to be more efficient, and reduces overall complexities and costs. Register Now!
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!